FDA approves new treatment for varicose veins


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — The Food and Drug Administration has approved a new technique for treating varicose veins by sealing them with a clear liquid that turns into a solid adhesive.

The VenaSeal system is approved for patients with varicose veins of the legs that cause pain, blood clots or other symptoms. The system includes syringes, guide wire and a catheter which is used to inject the liquid that seals the diseased veins. Doctors monitor the procedure using ultrasound imaging.

Previous techniques used to treat varicose veins involved drugs, lasers, radio waves or incisions. An FDA official said in a statement the new technique "can allow patients to quickly return to their normal activities, with less bruising."

The VenaSeal system was developed by Covidien, which was recently acquired by Minnesota-based Medtronic Inc.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
    Newsletter Signup

    KSL Weather Forecast

    KSL Weather Forecast
    Play button